Deferiprone in Alzheimer Disease 🔗 Access full article via JAMA NeurologyThis randomized clinical trial investigates whether the brain-permeable iron chelator deferiprone slows cognitive decline in people with Alzheimer disease. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
